A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Dendritic cells are rare haematopoietic cells that reside in a number of organs and tissues. By capturing, processing and presenting antigens to T cells, dendritic cells are essential for immune surveillance and the regulation of specific immunity. Several members of the tumour necrosis factor receptor (TNFR) superfamily are integral to the regulation of the immune response. These structurally related proteins modulate cellular functions ranging from proliferation and differentiation to inflammation and cell survival or deaths. The functional activity of dendritic cells is greatly increased by signalling through the TNFR family member CD40. Here we report the characterization of RANK (for receptor activator of NF-kappaB), a new member of the TNFR family derived from dendritic cells, and the isolation of a RANK ligand (RANKL) by direct expression screening. RANKL augments the ability of dendritic cells to stimulate naive T-cell proliferation in a mixed lymphocyte reaction, and increases the survival of RANK+ T cells generated with interleukin-4 and transforming growth factor (TGF)-beta. Thus RANK and RANKL seem to be important regulators of interactions between T cells and dendritic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The receptor that mediates all known activities for RANKL is called receptor activator of nuclear factor B (RANK) (Figs. 1 and 2).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [41]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Self-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cited by
Items 501–600 of 1,012
Genetics of age at menarche: a systematic review
Dvornyk, V., & Waqar-ul-Haq (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr050 · Cited by 125
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling
Strickson, S., Emmerich, C. H., Goh, E. T. H., Zhang, J., Kelsall, I. R., Macartney, T., Hastie, C. J., Knebel, A., Peggie, M., Marchesi, F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702367114 · Cited by 120
Storni, T., Lechner, F., Erdmann, I., Bächi, T., Jegerlehner, A., Dumrese, T., Kündig, T. M., Ruedl, C., & Bachmann, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2880 · Cited by 119
T cell life and death signalling via TNF-receptor family members
Screaton, G. R., & Xu, X. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00093-5 · Cited by 125
Giant Cell Tumor of Bone: An Update
Mallick, A. B., & Chawla, S. P. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01047-5 · Cited by 124
Hasegawa, T., Yoshimura, Y., Kikuiri, T., Yawaka, Y., Takeyama, S., Matsumoto, A., Oguchi, H., & Shirakawa, T. (2002) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2002.01603.x · Cited by 124
Dendritic Cells Are Resistant to Apoptosis Through the Fas (CD95/APO-1) Pathway
Ashany, D., Savir, A., Bhardwaj, N., & Elkon, K. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5303 · Cited by 124
Akatsu, T., Murakami, T., Nishikawa, M., Ono, K., Shinomiya, N., Tsuda, E., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Higashio, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9294 · Cited by 123
Sutjandra, L., Rodriguez, R. D., Doshi, S., Ma, M., Peterson, M. C., Jang, G. R., Chow, A. T., & Ruixo, J. J. P. (2011) · Clinical Pharmacokinetics · doi:10.2165/11594240-000000000-00000 · Cited by 123
Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy
Ahern, E. S., Smyth, M. J., Dougall, W. C., & Teng, M. W. L. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0095-y · Cited by 122
Self-citationRegulation of osteoclast function
Nakamura, I., Takahashi, N., Jimi, E., Udagawa, N., & Suda, T. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0530-8 · Cited by 122
Deuell, K. A., Callegari, A., Giachelli, C. M., Rosenfeld, M. E., & Scatena, M. (2012) · Journal of Vascular Research · doi:10.1159/000341216 · Cited by 121
Fujisaki, K., Tanabe, N., Suzuki, N., Kawato, T., Takeichi, O., Tsuzukibashi, O., Makimura, M., Ito, K., & Maeno, M. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.037 · Cited by 121
Hsu, Y., Niu, T., Terwedow, H. A., Xu, X. P., Feng, Y., Li, Z., Brain, J. D., Rosen, C. J., Laird, N. M., & Xu, X. (2005) · Human Genetics · doi:10.1007/s00439-005-0062-4 · Cited by 121
Evaluation of the role of RANK and OPG genes in Paget’s disease of bone
Wuyts, W. A., Wesenbeeck, L. V., Morales-Piga, A. A., Ralston, S. H., Hocking, L. J., Vanhoenacker, F. M. H. M., Westhovens, R., Verbruggen, L., Anderson, D. M., Hughes, A., et al. (2001) · Bone · doi:10.1016/s8756-3282(00)00411-7 · Cited by 121
Self-citationMohamed, S. G.-K., Sugiyama, E., Shinoda, K., Taki, H., Hounoki, H., Abdel-Aziz, H. O., Maruyama, M., Kobayashi, M., Ogawa, H., & Miyahara, T. (2007) · Bone · doi:10.1016/j.bone.2007.05.016 · Cited by 120
Ikeda, T., Utsuyama, M., & Hirokawa, K. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1416 · Cited by 107
Willems, F., Amraoui, Z., Vanderheyde, N., Verhasselt, V., Aksoy, E., Scaffidi, C., Peter, M. E., Krammer, P. H., & Goldman, M. (2000) · Blood · doi:10.1182/blood.v95.11.3478 · Cited by 111
Silvestrini, G., Ballanti, P., Patacchioli, F. R., Leopizzi, M., Gualtieri, N., Monnazzi, P., Tremante, E., Sardella, D., & BONUCCI, E. (2005) · The Histochemical Journal · doi:10.1007/s10735-004-3839-1 · Cited by 119
Regulation of osteoclast activity
Greenfield, E. M., Bi, Y., & Miyauchi, A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00156-3 · Cited by 119
Regulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 119
Bone morphogenetic protein signaling in prostate cancer cell lines
Brubaker, K. D., Corey, E., Brown, L. G., & Vessella, R. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10679 · Cited by 119
Danks, L., & Takayanagi, H. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt049 · Cited by 119
The KRN mouse model of inflammatory arthritis
Kyburz, D., & Corr, M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0131-5 · Cited by 118
Activin A Is an Essential Cofactor for Osteoclast Induction
Fuller, K., Bayley, K. E., & Chambers, T. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2075 · Cited by 118
Prostaglandins and bone metabolism
Choudhary, S., & Pilbeam, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00051-8 · Cited by 118
Bones in coeliac disease: diagnosis and treatment
Corazza, G. R., Stefano, M. D., Mauriño, E. C., & Bai, J. C. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.01.002 · Cited by 117
Tsurukai, T., Udagawa, N., Matsuzaki, K., Takahashi, N., & Suda, T. (2000) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740070018 · Cited by 117
Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength
Perrien, D. S., Akel, N. S., Edwards, P. K., Carver, A. A., Bendre, M. S., Swain, F. L., Skinner, R. A., Hogue, W. R., Nicks, K. M., Pierson, T. M., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0848 · Cited by 110
Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels
Kondo, T., Kitazawa, R., Yamaguchi, A., & Kitazawa, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21414 · Cited by 103
RANK, RANKL and osteoprotegerin in arthritic bone loss
Bezerra, M. C., de Carvalho, J. F., Prokopowitsch, A. S., & Pereira, R. M. R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000200004 · Cited by 115
Efficient Norovirus and Reovirus Replication in the Mouse Intestine Requires Microfold (M) Cells
Gonzalez-Hernandez, M. B., Liu, T., Payne, H. C., Stencel-Baerenwald, J., Ikizler, M. R., Yagita∥, H., Dermody, T. S., Williams, I. R., & Wobus, C. E. (2014) · Journal of Virology · doi:10.1128/jvi.00204-14 · Cited by 114
How B cells influence bone biology in health and disease
Horowitz, M. C., Fretz, J. A., & Lorenzo, J. A. (2010) · Bone · doi:10.1016/j.bone.2010.06.011 · Cited by 105
Hormonal contraception and bone metabolism: a systematic review
Nappi, C., Bifulco, G., Tommaselli, G. A., Gargano, V., & Carlo, C. D. (2012) · Contraception · doi:10.1016/j.contraception.2012.04.009 · Cited by 114
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
Sordillo, E. M., & Pearse, R. N. (2003) · Cancer · doi:10.1002/cncr.11134 · Cited by 114
Required and nonessential functions of nuclear factor-kappa B in bone cells
Boyce, B. F., Xing, L., Franzoso, G., & Siebenlist, U. K. (1999) · Bone · doi:10.1016/s8756-3282(99)00105-2 · Cited by 115
Dubois, B., Barthélémy, C., Durand, I., Liu, Y.-J., Caux, C., & Brière, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3428 · Cited by 114
Virk, M. S., & Lieberman, J. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2169 · Cited by 114
Bone diseases in patients with chronic liver disease
Jeong, H., & Kim, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174270 · Cited by 113
“Thus RANKL/RANK signaling can regulate osteoclast formation, activation and survival in normal bone modeling and remodeling and in a variety of pathologic conditions characterized by increased bone turnover [79,83,85,86].”
BackgroundGenetics and Epigenetics in Allergic Rhinitis
Choi, B. Y., Han, M. S., Kwak, J. W., & Kim, T. H. (2021) · Genes · doi:10.3390/genes12122004 · Cited by 113
Cytokines regulating osteoclast formation and function
Lee, S.-K., & Lorenzo, J. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231911.42666.78 · Cited by 104
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.12.2274 · Cited by 98
Khastgir, G., Studd, J., Holland, N., Alaghband-Zadeh, J., Fox, S., & Chow, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7161 · Cited by 97
Hofbauer, L. C., & Heufelder, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200102)44:2<253::aid-anr41>3.0.co;2-s · Cited by 113
Bharti, A. C., Takada, Y., Shishodia, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308062200 · Cited by 112
c- myc Is Required for Osteoclast Differentiation
Battaglino, R. A., Kim, D., Fu, J. Q., Vaage, B., Fu, X.-Y., & Stashenko, P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.763 · Cited by 112
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Napoli, N., Strollo, R., Paladini, A., Briganti, S., Pozzilli, P., & Epstein, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/690783 · Cited by 110
So, H., Rho, J., Jeong, D., Park, R., Fisher, D. E., Ostrowski, M. C., Choi, Y., & Kim, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302940200 · Cited by 97
Arko, B., Preželj, J., Komel, R., Kocijančič, A., Hudler, P., & Marc, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020124 · Cited by 105
Opg, Rank, and Rankl in Tooth Development: Co-ordination of Odontogenesis and Osteogenesis
Ohazama, A., Courtney, J., & Sharpe, P. T. (2004) · Journal of Dental Research · doi:10.1177/154405910408300311 · Cited by 111
Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells
Kiesel, J. R., Buchwald, Z. S., & Aurora, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803897 · Cited by 109
Oda, T., Yoshie, H., & Yamazaki, K. (2003) · Oral Microbiology and Immunology · doi:10.1034/j.1399-302x.2003.180105.x · Cited by 109
Maruyama, K., Takada, Y., Ray, N., Kishimoto, Y., Penninger, J. M., Yasuda, H., & Matsuo, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3799 · Cited by 105
So, T., Lee, S., & Croft, M. (2006) · International Journal of Hematology · doi:10.1532/ijh97.05120 · Cited by 109
The Role of TGF-β in Bone Metastases
Trivedi, T., Pagnotti, G. M., Guise, T. A., & Mohammad, K. S. (2021) · Biomolecules · doi:10.3390/biom11111643 · Cited by 108
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
Zavrski, I., Krebbel, H., Wildemann, B., Heider, U., Kaiser, M., Possinger, K., & Sezer, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.098 · Cited by 108
Vitamin D3 Augments Osteoclastogenesis via Vitamin D-Responsive Element of Mouse RANKL Gene Promoter
Kitazawa, R., & Kitazawa, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6251 · Cited by 108
T Lymphocyte–Deficient Mice Lose Trabecular Bone Mass With Ovariectomy
Lee, S.-K., Kadono, Y., Okada, F., Jacquin, C., Koczon-Jaremko, B., Gronowicz, G., Adams, D. J., Aguila, H. L., Choi, Y., & Lorenzo, J. A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060726 · Cited by 106
Ju, J. H., Cho, M.-L., Moon, Y.-M., Oh, H.-J., Park, J.-S., Jhun, J.-Y., Min, S.-Y., Cho, Y.-G., Park, K.-S., Yoon, C.-H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1507 · Cited by 100
Hakeda, Y., Kobayashi, Y., Yamaguchi, K., Yasuda, H., Tsuda, E., Higashio, K., Miyata, T., & Kumegawa, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9523 · Cited by 107
NICHOLSON, G. C., MALAKELLIS, M., COLLIER, F. M., CAMERON, P. U., HOLLOWAY, W. R., GOUGH, T. J., GREGORIO-KING, C., KIRKLAND, M. A., & MYERS, D. E. (2000) · Clinical Science · doi:10.1042/cs0990133 · Cited by 107
Molecular determinants for the polarization of macrophage and osteoclast
Yang, D., & Wan, Y. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00754-3 · Cited by 107
Ofotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 107
Grčević, D., Lee, S.-K., Marušić, A., & Lorenzo, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4231 · Cited by 99
Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue
Santos, C. F., Morandini, A. C., Dionísio, T. J., de Faria, F. A. C., Lima, M. C., Figueiredo, C. M., Ishikiriama, B. L. C., Sipert, C. R., Maciel, R. P., Akashi, A. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134601 · Cited by 106
Expression and function of TNF-family proteins and receptors in human osteoblasts>
Bu, R., Borysenko, C. W., Li, Y., Cao, L., Sabokbar, A., & Blair, H. C. (2003) · Bone · doi:10.1016/j.bone.2003.07.006 · Cited by 106
TRAF2 Is Essential for TNF-α-Induced Osteoclastogenesis
Kanazawa, K., & Kudo, A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041225 · Cited by 97
Ohno, H., Kubo, K., Murooka, H., Kobayashi, Y., Nishitoba, T., Shibuya, M., Yoneda, T., & Isoe, T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0313 · Cited by 97
Atkins, G. J., Bouralexis, S., Haynes, D. R., Graves, S. E., Geary, S. M., Evdokiou, A., Zannettino, A. C. W., Hay, S., & Findlay, D. M. (2001) · Bone · doi:10.1016/s8756-3282(01)00404-5 · Cited by 105
Hatakeyama, J., Sreenath, T., Hatakeyama, Y., Thyagarajan, T., Shum, L., Gibson, C. W., Wright, J. T., & Kulkarni, A. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306284200 · Cited by 105
Pneumaticos, S. G., Triantafyllopoulos, G. K., Basdra, E. K., & Papavassiliou, A. G. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01062.x · Cited by 104
Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis
Goater, J. J., O'Keefe, R. J., Rosier, R. N., Puzas, J. E., & Schwarz, E. M. (2002) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(01)00083-3 · Cited by 103
RANK/RANKL/OPG role in distraction osteogenesis
Pérez‐Sayáns, M., Martín, J. M. S., Barros, F., Rey, J. M. G., & García, A. G. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.10.042 · Cited by 104
Capparelli, C., Morony, S., Warmington, K., Adamu, S., Lacey, D., Dunstan, C. R., Stouch, B., Martin, S., & Kostenuik, P. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.852 · Cited by 103
“OPG acts as a soluble decoy receptor that prevents RANK ligand (RANKL, also known as OPG ligand [OPGL],((2)) TRANCE,((3)), and ODF((4))) from binding to RANK on osteoclasts.”
BackgroundTanabe, N., Maeno, M., Suzuki, N., Fujisaki, K., Tanaka, H., Ogiso, B., & Ito, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.079 · Cited by 103
Giannakoulas, N., Ntanasis-Stathopoulos, I., & Terpos, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094462 · Cited by 87
Low-energy irradiation stimulates formation of osteoclast-like cells via RANK expression in vitro
Aihara, N., Yamaguchi, M., & Kasai, K. (2006) · Lasers in Medical Science · doi:10.1007/s10103-005-0368-4 · Cited by 103
Guerrini, M. M., Okamoto, K., Komatsu, N., Sawa, S., Danks, L., Penninger, J. M., Nakashima, T., & Takayanagi, H. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.017 · Cited by 103
Chen, N., Huang, M.-W., & Hsieh, S.-L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.270 · Cited by 102
Signal transduction pathways regulating osteoclast differentiation and function
Tanaka, S., Nakamura, I., Inoue, J., Oda, H., & Nakamura, K. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740300021 · Cited by 102
Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours
Gibiansky, L. V., Sutjandra, L., Doshi, S., Zheng, J., Sohn, W. Y., Peterson, M. C., Jang, G. R., Chow, A. T., & Ruixo, J. J. P. (2012) · Clinical Pharmacokinetics · doi:10.2165/11598090-000000000-00000 · Cited by 101
Nagai, M., Kyakumoto, S., & Sato, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2314 · Cited by 101
Rea, S. L., Walsh, J. P., Ward, L., Yip, K., Ward, B. K., Kent, G. N., Steer, J. H., Xu, J., & Ratajczak, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060405 · Cited by 93
Prostaglandins and Bone Metabolism
Pilbeam, C. C., Harrison, J. R., & Raisz, L. G. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50156-6 · Cited by 101
Kitaura, H., Kimura, K., Ishida, M., Sugisawa, H., Kohara, H., Yoshimatsu, M., & Takano‐Yamamoto, T. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/617032 · Cited by 100
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
McGonigle, J. S., Giachelli, C. M., & Scatena, M. (2008) · Angiogenesis · doi:10.1007/s10456-008-9127-z · Cited by 100
RANKL and RANK: From Mammalian Physiology to Cancer Treatment
Rao, S., Cronin, S. J. F., Sigl, V., & Penninger, J. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.001 · Cited by 100
Takami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J.-T., Martin, T. J., Nagai, K., & Suda, T. (2000) · Endocrinology · doi:10.1210/endo.141.12.7852 · Cited by 93
Molecular control of bone remodeling and osteoporosis
Kong, Y., & Penninger, J. M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00178-9 · Cited by 100
Lindberg, M., Erlandsson, M., Alatalo, S., Windahl, S., Andersson, G., Halleen, J., Carlsten, H., Gustafsson, J., & Ohlsson, C. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1710425 · Cited by 91
Gomez‐Aleza, C., Nguyen, B., Yoldi, G., Ciscar, M., Barranco, A., Hernández-Jiménez, E., Maetens, M., Salgado, R., Zafeiroglou, M., Pellegrini, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20138-8 · Cited by 99
Low, E., Zoellner, H. F., Kharbanda, O. P., & Darendeliler, M. A. (2005) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2004.03.038 · Cited by 99
1α,25 Dihydroxyvitamin D3 Rapidly Regulates the Mouse Osteoprotegerin Gene Through Dual Pathways
Kondo, T., Kitazawa, R., Maeda, S., & Kitazawa, S. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040604 · Cited by 99
来海, 慶., Kajiya, H., Nakayama, S., Ikebe, T., & Okabe, K. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0596-4 · Cited by 99
Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes
Mosheimer, B. A., Kaneider, N. C., Feistritzer, C., Djanani, A. M., Sturn, D. H., Patsch, J. R., & Wiedermann, C. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1895 · Cited by 90
Dendritic Cells at the Osteo-Immune Interface: Implications for Inflammation-Induced Bone Loss
Alnaeeli, M., Park, J., Mahamed, D., Penninger, J. M., & Teng, Y.-T. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070314 · Cited by 93
Li, B., Wang, P., Jiao, J., Wei, H., Xu, W., & Zhou, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824117 · Cited by 98
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Anastasilakis, A. D., Toulis, K. A., Πολύζος, Σ., Anastasilakis, C. D., & Makras, P. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s24239 · Cited by 98
Tanaka, H., Tanabe, N., Shoji, M., Suzuki, N., Katono, T., Sato, S., Motohashi, M., & Maeno, M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.08.017 · Cited by 98
Low-level laser therapy enhances the expression of osteogenic factors during bone repair in rats
Tim, C. R., Pinto, K. N. Z., Rossi, B. R. O., Fernandes, K. R., Matsumoto, M. A., Parizotto, N. A., & Rennó, A. C. M. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1302-9 · Cited by 98
Metadata
- Authors
- Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L.
- Corresponding author
- Anderson, Dirk M.
- Venue
- Nature
- Published
- 1997-11
- Volume
- 390
- Issue
- 6656
- Pages
- 175-179
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1650001464
- Cited by
- 2,290
- References
- 30
- Citations by year
- 2026: 31 · 2025: 32 · 2024: 37 · 2023: 45 · 2022: 53 · 2021: 79 · 2020: 74 · 2019: 63 · 2018: 56 · 2017: 71 · 2016: 53 · 2015: 73 · 2014: 80 · 2013: 83 · 2012: 94
- FWCI
- 37.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- RANK, RANK ligand, TNF receptor superfamily, dendritic cells, T cell proliferation, T cell survival, antigen presentation, immune regulation, IL-4, TGF-beta, mixed lymphocyte reaction
- MeSH terms
- Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Cells, Cultured, Chromosome Mapping, Chromosomes, Human, Pair 13, Chromosomes, Human, Pair 18, Dendritic Cells, Humans, Ligands, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, T-Lymphocytes, Transfection, Sequence Homology, Amino Acid, Receptors, Tumor Necrosis Factor, CD40 Ligand, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.